Concepedia

Author

Anna Djos

University of GothenburgORCID

Also Known As

A Djos, A. Djos, ANNA DJOS, Anna Djos

67

Publications

928

Citations

15

H-Index

25

Concepts

All Affiliations

University of GothenburgKarolinska InstitutetSahlgrenska University HospitalUniversitat de ValènciaKarolinska University Hospital
AD

About

Anna Djos is an author at University of Gothenburg specializing in medicine, tumor biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

218

2

Pathology

3

3

70

3

Cell Biology

2

2

148

4

Biostatistics

1

1

25

5

Molecular Biology

1

1

26

Anna Djos

×

16

Publications

876

Citations

15

H-Index

YearCitations

Emergence of New <i>ALK</i> Mutations at Relapse of Neuroblastoma

Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard,

Journal of Clinical Oncology

2014

204

Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells

Christina Schönherr, Kristina Ruuth, Sattu Kamaraj,

Oncogene

2012

122

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma

Anna Djos, Tommy Martinsson, Per Kogner,

Molecular Cancer

2012

86

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma

Helena Carén, Anna Djos, Maria Nethander,

BMC Cancer

2011

76

Intragenic anaplastic lymphoma kinase (<i>ALK</i>) rearrangements: Translocations as a novel mechanism of <i>ALK</i> activation in neuroblastoma tumors

Susanne Fransson, Magnus Hansson, Kristina Ruuth,

Genes Chromosomes and Cancer

2014

52

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas

Ganesh Umapathy, Jikui Guan, Dan Gustafsson,

Science Signaling

2017

51

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

Joachim T. Siaw, Niloufar Javanmardi, Jimmy Van den Eynden,

Cell Reports

2020

51

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion

Eva Villamón, Ana P. Berbegall, Marta Piqueras,

PLoS ONE

2013

43

METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

Roshan Vaid, Ketan Thombare, Akram Mendez,

Nucleic Acids Research

2023

42

Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

Ana P. Berbegall, Eva Villamón, Marta Piqueras,

Oncogene

2015

29

Page 1